AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN FIRST REMISSION IMPROVES OUTCOME IN ADULT PATIENTS (PTS) WITH LYMPHOBLASTIC LYMPHOMA (LBL) -RESULTS FROM A RANDOMIZED TRIAL OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT) AND THE UK LYMPHOMA GROUP (UKLG)
Citation
G. Santini et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN FIRST REMISSION IMPROVES OUTCOME IN ADULT PATIENTS (PTS) WITH LYMPHOBLASTIC LYMPHOMA (LBL) -RESULTS FROM A RANDOMIZED TRIAL OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT) AND THE UK LYMPHOMA GROUP (UKLG), Bone marrow transplantation, 21, 1998, pp. 624-624
Categorie Soggetti
Hematology,Oncology,Immunology,Transplantation
SICI code
0268-3369(1998)21:<624:AST(IF>2.0.ZU;2-0